Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine)

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02908776` - MYocardial DAmage AND MIcrobiota STUDY	N/A
Recruiting	`NCT01397994` - Study to Assess Efficacy of Nicorandil+Atenolol vs Atenolol in Treatment of Chronic Stable Angina.	Phase 4
Active, not recruiting	`NCT00350922` - A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina	Phase 1
Completed	`NCT02078921` - The Effects of Inorganic Nitrate on Cardiac Muscle in Angina	Phase 2
Completed	`NCT02591758` - Novel Vitality Indices Derived From the Hexoskin in Patients Affected With Angina Undergoing Coronary Revascularization or Medical Therapy
Terminated	`NCT03346278` - Text Message Intervention to Improve Cardiac Rehab Participation	N/A
Active, not recruiting	`NCT06249581` - Pharmacokinetics of AUX-001 40mg Once-daily in Healthy Subjects Under Fasting and Fed Conditions	Early Phase 1
Enrolling by invitation	`NCT03063697` - Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension, Chronic Stable Angina and Congestive Heart Failure	N/A
Completed	`NCT01239511` - Phase IIb Study of STA-2 in Patients With Chronic Stable Angina	Phase 2
Completed	`NCT02722213` - Mindfulness & Stress Management Study for Cardiac Patients	N/A
Completed	`NCT01484912` - Phase II Study of STA-2 in Patients With Chronic Stable Angina	Phase 2
Recruiting	`NCT03507361` - Myocardial Damage and Music Study	N/A
Recruiting	`NCT03834155` - Enhancing Cardiac Rehabilitation Through Behavioral Nudges	N/A
Active, not recruiting	`NCT02710435` - REDUCER-I: An Observational Study of the Neovasc Reducer™ System
Withdrawn	`NCT00518921` - Capadenoson in Angina Pectoris	Phase 2
Withdrawn	`NCT02423265` - Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries	Phase 4
Completed	`NCT01369472` - Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule	Phase 1
Completed	`NCT01340248` - A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokinetics of Dilatrend SR 64mg Capsule After Oral Administration in Healthy Male Volunteers	Phase 1
Completed	`NCT02315001` - Liraglutide to Improve corONary Haemodynamics During Exercise streSS	Phase 2
Completed	`NCT01760083` - A Randomized Multicentre Trial to Evaluate the Utilization of Revascularization or Optimal Medical Therapy for the Treatment of Chronic Total Coronary Occlusions	N/A

NCT number	NCT03486561
Study type	Interventional
Source	OBS Pakistan
Contact	Faizan Shaukat
Phone	+923328814816
Email	faizan.shaukat@obs.com.pk
Status	Not yet recruiting
Phase	Phase 4
Start date	April 1, 2018
Completion date	October 31, 2018

Management of Ischemic Heart Disease With Angiwell-XR (Ranolazine) — MIDA

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms